Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Sponsor
Purdue Pharma LP (Industry)
Overall Status
Completed
CT.gov ID
NCT01427270
Collaborator
(none)
455
194
3
38
2.3
0.1

Study Details

Study Description

Brief Summary

The primary objective is to assess the efficacy of oxycodone/naloxone (OXN) for the management of opioid-induced constipation (OIC) compared to oxycodone controlled-release tablets (OXY) in subjects with moderate to severe low back pain and OIC who require around-the-clock opioid therapy.

Condition or Disease Intervention/Treatment Phase
  • Drug: Oxycodone/Naloxone controlled-release
  • Drug: Oxycodone HCl controlled-release
  • Drug: Placebo
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
455 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
A Randomized, Double-blind, Double-dummy, Placebo-controlled, Active-controlled, Parallel-group, Multicenter Trial of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess the Analgesic Efficacy (Compared to Placebo) and the Management of Opioid-induced Constipation (Compared to Oxycodone Controlled-release Tablets (OXY)) in Opioid-experienced Subjects With Uncontrolled Moderate to Severe Chronic Low Back Pain and a History of Opioid-induced Constipation Who Require Around-the-clock Opioid Therapy
Study Start Date :
Aug 1, 2011
Actual Primary Completion Date :
Oct 1, 2014
Actual Study Completion Date :
Oct 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: OXN

Oxycodone/Naloxone controlled-release tablets (OXN)

Drug: Oxycodone/Naloxone controlled-release
Oxycodone/Naloxone controlled-release tablets (10/5 - 40/20 mg) taken orally every 12 hours

Active Comparator: OXY

Oxycodone HCl controlled-release tablets (OXY)

Drug: Oxycodone HCl controlled-release
Oxycodone HCl controlled-release tablets (10 - 40 mg) taken orally every 12 hours
Other Names:
  • OxyContin
  • Placebo Comparator: Placebo

    Placebo tablets to match OXN or OXY

    Drug: Placebo
    Placebo tablets to match OXN or OXY taken orally every 12 hours

    Outcome Measures

    Primary Outcome Measures

    1. Overall complete spontaneous bowel movement (CSBM) responder rates [Weeks 1 through 12]

      The overall Complete Spontaneous Bowel Movement (CSBM) responder rates over the 12 week double-blind period comparing OXN to OXY

    Secondary Outcome Measures

    1. CSBM Responder at least 50% of the weeks in the double-blind period [Weeks 1 through 12]

    2. Laxative-free Responder at least 50% of the weeks in the double-blind period [Weeks 1 through 12]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria include:
    • Male and female subjects ≥ 18 years of age with moderate to severe, chronic low back pain (lasting at least several hours daily) as their predominant pain condition for at least 3 months prior to screening period;

    • The low back pain must be related to nonmalignant and nonneuropathic conditions and may be with or without radiation;

    • Subjects must have a self-reported history of opioid induced constipation (OIC).

    Exclusion Criteria include:
    • Subjects with rheumatoid arthritis or other inflammatory arthritis;

    • Subjects with neuropathic conditions that have been painful or required therapy within the past 3 months;

    • Subjects with evidence of significant structural abnormalities of the gastrointestinal (GI) tract or other significant conditions affecting GI motility;

    • Subjects with chronic constipation not related to opioid use;

    • Subjects who had surgical procedures directed towards the source of chronic low back pain within 6 months of the screening visit or planned during the study;

    • Subjects with a history of malignancy within the past 2 years, with the exception of basal cell carcinoma that has been successfully treated.

    Other protocol specific inclusion/exclusion criteria may apply.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Investigational Site Alabaster Alabama United States 35007
    2 Investigational Site Birmingham Alabama United States 35242
    3 Investigational Site Gulf Shores Alabama United States 36542
    4 Investigational Site Homewood Alabama United States 35209
    5 Investigational Site Huntsville Alabama United States 35801
    6 Investigational Site Mobile Alabama United States 36608
    7 Investigational Site Goodyear Arizona United States 85395-2511
    8 Investigational Site Goodyear Arizona United States 85395
    9 Investigational Site Phoenix Arizona United States 85018
    10 Investigational Site Phoenix Arizona United States 85027
    11 Investigational Site Tempe Arizona United States 85282
    12 Investigational Site Tucson Arizona United States 85704
    13 Investigational Site Hot Springs Arkansas United States 71901
    14 Investigational Site Little Rock Arkansas United States 72211
    15 Investigational Site Anaheim California United States 92801
    16 Investigational Site Anaheim California United States 92804
    17 Investigational Site Anaheim California United States 92805
    18 Investigational Site Chino California United States 91710
    19 Investigational Site Fresno California United States 93720
    20 Investigational Site Fresno California United States 93726
    21 Investigational Site Glendale California United States 91206
    22 Investigational Site La Mesa California United States 91942
    23 Investigational Site Laguna Hills California United States 92637
    24 Investigational Site Long Beach California United States 90806
    25 Investigational Site Los Angeles California United States 90017
    26 Investigational Site Los Angeles California United States 90025
    27 Investigational Site Los Angeles California United States 90036
    28 Investigational Site Los Gatos California United States 95032
    29 Investigational Site National City California United States 91950
    30 Investigational Site North Hollywood California United States 91606
    31 Investigational Site Oceanside California United States 92056
    32 Investigational Site Paramount California United States 90723
    33 Investigational Site Richmond California United States 94806
    34 Investigational Site Roseville California United States 95661
    35 Investigational Site Sacramento California United States 95823
    36 Investigational Site Sacramento California United States 95842
    37 Investigational Site San Diego California United States 92114
    38 Investigational Site Santa Ana California United States 92701
    39 Investigational Site Santa Clarita California United States 91350
    40 Investigational Site Valley Village California United States 91607
    41 Investigational Site Golden Colorado United States 80401
    42 Investigational Site New Haven Connecticut United States 06511
    43 Investigational Site Waterbury Connecticut United States 06708
    44 Investigational Site Aventura Florida United States 33180
    45 Investigational Site Boynton Beach Florida United States 33472
    46 Investigational Site Bradenton Florida United States 34209
    47 Investigational Site Clearwater Florida United States 33765
    48 Investigational Site Clermont Florida United States 34711
    49 Investigational Site Coral Gables Florida United States 33134
    50 Investigational Site Daytona Beach Florida United States 32117
    51 Investigational Site Ft. Lauderdale Florida United States 33316
    52 Investigational Site Hialeah Florida United States 33012
    53 Investigational Site Hialeah Florida United States 33013
    54 Investigational Site Inverness Florida United States 34452
    55 Investigational Site Jacksonville Florida United States 32216
    56 Investigational Site Jacksonville Florida United States 32257
    57 Investigational Site Jupiter Florida United States 33458
    58 Investigational Site Miami Lakes Florida United States 33014
    59 Investigational Site Miami Florida United States 33125
    60 Investigational Site Miami Florida United States 33126
    61 Investigational Site Miami Florida United States 33135
    62 Investigational Site Miami Florida United States 33143
    63 Investigational Site Miami Florida United States 33185
    64 Investigational Site Naples Florida United States 34110
    65 Investigational Site Naples Florida United States 34113
    66 Investigational Site New Port Richey Florida United States 34652
    67 Investigational Site North Miami Beach Florida United States 33162
    68 Investigational Site Orlando Florida United States 32806
    69 Investigational Site Oviedo Florida United States 32765
    70 Investigational Site Pinellas Park Florida United States 33781
    71 Investigational Site Pinellas Park Florida United States 33782
    72 Investigational Site Plantation Florida United States 33317
    73 Investigational Site Port Orange Florida United States 32129
    74 Investigational Site Sanford Florida United States 32771
    75 Investigational Site South Miami Florida United States 33143
    76 Investigational Site Tamarac Florida United States 33321
    77 Investigational Site Tampa Florida United States 33607
    78 Investigational Site Tampa Florida United States 33613
    79 Investigational Site Wellington Florida United States 33414
    80 Investigational Site Austell Georgia United States 30106
    81 Investigational Site Blue Ridge Georgia United States 30513
    82 Investigational Site Canton Georgia United States 30114
    83 Investigational Site Columbus Georgia United States 31904
    84 Investigational Site Johns Creek Georgia United States 30097
    85 Investigational Site Marietta Georgia United States 30060
    86 Investigational Site Perry Georgia United States 31069
    87 Investigational Site Savannah Georgia United States 31405
    88 Investigational Site Boise Idaho United States 83702
    89 Investigational Site Meridian Idaho United States 83642
    90 Investigational Site Bloomington Illinois United States 61701
    91 Investigational Site Chicago Illinois United States 60657
    92 Investigational Site Evansville Indiana United States 47714
    93 Investigational Site Kansas City Kansas United States 66160
    94 Investigational Site Wichita Kansas United States 67203
    95 Investigational Site Lexington Kentucky United States 40504
    96 Investigational Site Madisonville Kentucky United States 42431
    97 Investigational Site Baton Rouge Louisiana United States 70809
    98 Investigational Site Covington Louisiana United States 70435
    99 Investigational Site Marrero Louisiana United States 70072
    100 Investigational Site Metairie Louisiana United States 70006
    101 Investigational Site Hollywood Maryland United States 20636
    102 Investigational Site Fall River Massachusetts United States 02720
    103 Investigational Site North Attleboro Massachusetts United States 02760
    104 Investigational Site Bay City Michigan United States 48706
    105 Investigational Site Pinconning Michigan United States 48650
    106 Investigational Site Rochester Michigan United States 48307
    107 Investigational Site Troy Michigan United States 48085
    108 Investigational Site Hazelwood Missouri United States 63042
    109 Investigational Site St. Louis Missouri United States 63128
    110 Investigational Site St. Louis Missouri United States 63141
    111 Investigational Site Las Vegas Nevada United States 89119
    112 Investigational Site Stratford New Jersey United States 08084
    113 Investigational Site Toms River New Jersey United States 08755
    114 Investigational Site Voorhees New Jersey United States 08034
    115 Investigational Site Albuquerque New Mexico United States 87106
    116 Investigational Site Cedarhurst New York United States 11516
    117 Investigational Site Great Neck New York United States 11023
    118 Investigational Site New Windsor New York United States 12553
    119 Investigational Site New York New York United States 10022
    120 Investigational Site North Massapequa New York United States 11758
    121 Investigational Site Williamsville New York United States 14221
    122 Investigational Site Elkin North Carolina United States 28621
    123 Investigational Site Winston-Salem North Carolina United States 27103
    124 Investigational Site Beavercreek Ohio United States 45432
    125 Investigational Site Cincinnati Ohio United States 45242
    126 Investigational Site Cleveland Ohio United States 44122
    127 Investigational Site Columbus Ohio United States 43210
    128 Investigational Site Columbus Ohio United States 43214
    129 Investigational Site Franklin Ohio United States 45005
    130 Investigational Site Groveport Ohio United States 43125
    131 Investigational Site Toledo Ohio United States 43623
    132 Investigational Site Oklahoma City Oklahoma United States 73119
    133 Investigational Site Altoona Pennsylvania United States 16602
    134 Investigational Site Jenkintown Pennsylvania United States 19046
    135 Investigational Site Johnstown Pennsylvania United States 15904
    136 Investigational Site Philadelphia Pennsylvania United States 19152
    137 Investigational Site Phoenixville Pennsylvania United States 19460
    138 Investigational Site Tipton Pennsylvania United States 16684
    139 Investigational Site Warwick Rhode Island United States 02886
    140 Investigational Site Myrtle Beach South Carolina United States 29588
    141 Investigational Site Spartanburg South Carolina United States 29303
    142 Investigational Site Franklin Tennessee United States 37067
    143 Investigational Site New Tazewell Tennessee United States 37825
    144 Investigational Site Arlington Texas United States 76011
    145 Investigational Site Athens Texas United States 75751
    146 Investigational Site Austin Texas United States 78756
    147 Investigational Site Dallas Texas United States 75231
    148 Investigational Site Dallas Texas United States 75251
    149 Investigational Site Houston Texas United States 77005
    150 Investigational Site Houston Texas United States 77024
    151 Investigational Site Houston Texas United States 77025
    152 Investigational Site Houston Texas United States 77030
    153 Investigational Site Houston Texas United States 77057
    154 Investigational Site Houston Texas United States 77065
    155 Investigational Site Houston Texas United States 77074
    156 Investigational Site Houston Texas United States 77098
    157 Investigational Site Humble Texas United States 77338
    158 Investigational Site North Richland Hills Texas United States 76180
    159 Investigational Site Plano Texas United States 75075
    160 Investigational Site San Antonio Texas United States 78229
    161 Investigational Site San Antonio Texas United States 78238
    162 Investigational Site Sugar Land Texas United States 77478
    163 Investigational Site Tomball Texas United States 77375
    164 Investigational Site Clinton Utah United States 84015
    165 Investigational Site Salt Lake City Utah United States 84102
    166 Investigational Site Salt Lake City Utah United States 84107
    167 Investigational Site West Jordan Utah United States 84088
    168 Investigational Site Richmond Virginia United States 23220
    169 Investigational Site Richmond Virginia United States 23235
    170 Investigational Site Virginia Beach Virginia United States 23454
    171 Investigational Site Brno Czech Republic 656 91
    172 Investigational Site Hradec Kralove Czech Republic 500 03
    173 Investigational Site Most Czech Republic 434 64
    174 Investigational Site Olomouc Czech Republic 775 20
    175 Investigational Site Praha 10 Czech Republic 100 00
    176 Investigational Site Praha 4 - Krc Czech Republic 140 59
    177 Investigational Site Praha 6 Czech Republic 160 00
    178 Investigational Site Rychnov nad Kneznou Czech Republic 516 01
    179 Investigational Site Sternberk Czech Republic 785 01
    180 Investigational Site Vysoke Myto Czech Republic 566 23
    181 Investigational Site Zlin Czech Republic 760 01
    182 Investigational Site Znojmo Czech Republic 669 02
    183 Investigational Site Catania Italy 95123
    184 Investigational Site Bielsko-Biala Poland 43-300
    185 Investigational Site Bydgoszcz Poland 85-079
    186 Investigational Site Bydgoszcz Poland 85-796
    187 Investigational Site Gdansk Poland 80-286
    188 Investigational Site Gdansk Poland 80-546
    189 Investigational Site Gdynia Poland 81-366
    190 Investigational Site Katowice Poland 40-084
    191 Investigational Site Katowice Poland 40-683
    192 Investigational Site Lublin Poland 20-582
    193 Investigational Site Lublin Poland 20-718
    194 Investigational Site Torun Poland 87-100

    Sponsors and Collaborators

    • Purdue Pharma LP

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Purdue Pharma LP
    ClinicalTrials.gov Identifier:
    NCT01427270
    Other Study ID Numbers:
    • ONU3704
    • 2011-005060-26
    First Posted:
    Sep 1, 2011
    Last Update Posted:
    Nov 7, 2014
    Last Verified:
    Nov 1, 2014

    Study Results

    No Results Posted as of Nov 7, 2014